- Reaction score
- 512
https://clinicaltrials.gov/ct2/show/NCT02781311
Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Study Type : Interventional (Clinical Trial)
Actual Enrollment : 169 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Actual Study Start Date : June 29, 2016
Estimated Primary Completion Date : April 5, 2018
Estimated Study Completion Date : June 5, 2018
In 6 months we will have more information ... maybe before.
Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Study Type : Interventional (Clinical Trial)
Actual Enrollment : 169 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Actual Study Start Date : June 29, 2016
Estimated Primary Completion Date : April 5, 2018
Estimated Study Completion Date : June 5, 2018
In 6 months we will have more information ... maybe before.